Abstract |
For efficient drug delivery, we introduce a click-chemistry-mediated two-step tumor-targeting strategy for nanoparticles (NPs). We modified HER2-binding trastuzumab with trans-cyclooctene (TCO-Trb), and fabricated tetrazine-modified NPs containing the anticancer drug, SN38 (SN38-Tz-NPs). To target tumor cells with the Tz-NPs, the tumor cells are first treated with TCO-Trb. The TCO-Trb binds HER2s and presents multiple TCO groups on the cell surface. Subsequently, the cells are treated with SN38-Tz-NPs that can bind the cell surface via click chemistry between Tz and TCO. This click chemistry-mediated binding resulted in enhanced tumor-targeting of Tz-NPs to the target tumor cells. In our study, this strategy was performed and analyzed in vitro and in vivo, and the results show that this is a promising strategy for tumor-targeted drug delivery by NPs.
|
Authors | Jihye Yoo, Sangkee Choi, Jihwan Son, Gawon Yi, Eunha Kim, Heebeom Koo |
Journal | Biochemical and biophysical research communications
(Biochem Biophys Res Commun)
Vol. 515
Issue 1
Pg. 207-213
(07 12 2019)
ISSN: 1090-2104 [Electronic] United States |
PMID | 31146921
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2019 Elsevier Inc. All rights reserved. |
Chemical References |
- Cyclooctanes
- Topoisomerase I Inhibitors
- Irinotecan
- Receptor, ErbB-2
- Trastuzumab
|
Topics |
- Animals
- Cell Line, Tumor
- Click Chemistry
(methods)
- Cyclooctanes
(chemistry)
- Drug Delivery Systems
(methods)
- Irinotecan
(administration & dosage, chemistry, pharmacokinetics)
- Mice, Inbred BALB C
- Mice, Nude
- Nanoparticles
(administration & dosage, chemistry)
- Neoplasms, Experimental
(drug therapy, metabolism, pathology)
- Protein Binding
- Receptor, ErbB-2
(genetics, metabolism)
- Tissue Distribution
- Topoisomerase I Inhibitors
(administration & dosage, chemistry, pharmacokinetics)
- Trastuzumab
(administration & dosage, chemistry, metabolism, pharmacokinetics)
|